Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease

V Panwar, A Singh, M Bhatt, RK Tonk… - Signal transduction and …, 2023 - nature.com
The mammalian target of rapamycin (mTOR) is a protein kinase that controls cellular
metabolism, catabolism, immune responses, autophagy, survival, proliferation, and …

Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer

L Yu, J Wei, P Liu - Seminars in cancer biology, 2022 - Elsevier
Cancer is the second leading cause of human death globally. PI3K/Akt/mTOR signaling is
one of the most frequently dysregulated signaling pathways observed in cancer patients that …

PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside

AS Alzahrani - Seminars in cancer biology, 2019 - Elsevier
Abstract Phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR)
signaling pathway is one of the major cellular signaling pathways that plays an important …

Recent advances and limitations of mTOR inhibitors in the treatment of cancer

ES Ali, K Mitra, S Akter, S Ramproshad, B Mondal… - Cancer cell …, 2022 - Springer
Abstract The PI3K-Akt-mechanistic (formerly mammalian) target of the rapamycin (mTOR)
signaling pathway is important in a variety of biological activities, including cellular …

Targeting mTOR for cancer therapy

H Hua, Q Kong, H Zhang, J Wang, T Luo… - Journal of hematology & …, 2019 - Springer
Mechanistic target of rapamycin (mTOR) is a protein kinase regulating cell growth, survival,
metabolism, and immunity. mTOR is usually assembled into several complexes such as …

Current treatment strategies for inhibiting mTOR in cancer

F Chiarini, C Evangelisti, JA McCubrey… - Trends in …, 2015 - cell.com
Mammalian target of rapamycin (mTOR) is a Ser/Thr kinase that regulates a wide range of
functions, including cell growth, proliferation, survival, autophagy, metabolism, and …

[HTML][HTML] mTOR function and therapeutic targeting in breast cancer

SH Hare, AJ Harvey - American journal of cancer research, 2017 - ncbi.nlm.nih.gov
The mTOR pathway was discovered in the late 1970s after the compound and natural
inhibitor of mTOR, rapamycin was isolated from the bacterium Streptomyces hygroscopicus …

TOR complexes and the maintenance of cellular homeostasis

S Eltschinger, R Loewith - Trends in cell biology, 2016 - cell.com
The Target of Rapamycin (TOR) is a conserved serine/threonine (ser/thr) kinase that
functions in two, distinct, multiprotein complexes called TORC1 and TORC2. Each complex …

[HTML][HTML] The phosphoinositide 3-kinase pathway and therapy resistance in cancer

KK Brown, A Toker - F1000prime reports, 2015 - ncbi.nlm.nih.gov
Abstract The phosphoinositide 3-kinase (PI3K)/Akt/mechanistic target of rapamycin (mTOR)
signaling network is a master regulator of processes that contribute to tumorigenesis and …

Potential therapeutic effects of mTOR inhibition in atherosclerosis

A Kurdi, GRY De Meyer… - British journal of clinical …, 2016 - Wiley Online Library
Despite significant improvement in the management of atherosclerosis, this slowly
progressing disease continues to affect countless patients around the world. Recently, the …